drugset / Trial / NCT03377595
Post C-Section Pain Control Using EXPAREL
RandomizedParallel-groupDouble-blindTreatment
Summary
Evaluating the safety and efficacy of EXPAREL (Liposomal Bupivacaine ) for pain control in patients undergoing scheduled cesarean section by giving it either as infiltration in Transversus Abdominis Plane after finishing the procedure or through wound infiltration into the fascia prior to closure of skin
Timeline
- Start
- 2019-07-02
- Primary completion
- 2019-08-30
- Completion
- 2019-09-01
Outcome
Outcome not reported
Stopped: “Lack of resources, no data collected”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 266 mg | Other |